Abstract 7334: Targeting Nectin-4 with a first-in-class triple MMAE/dual TOP1i payload ADC showing synergistic and durable activity across all target expression levels and favorable tolerability
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Araris Biotech AG (Switzerland)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409630526
